The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand for drug formulations and advancements in the pharmaceutical industry.

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...

It's time for us to pass this cost back to Big Pharma where it belongs,” Commissioner Cameron Davis said. “It's also time to not keep the burden on the shoulders of our taxpayers.” ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a micro-cap pharmaceutical company with a market capitalization of $1.43 million focused on non-addictive pain management treatments, has ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Kennedy managed to allay the concerns of several key GOP senators over his anti-vaccine activism. Mitch McConnell was the ...

The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

Italian drug maker Recordati raised on Thursday its core profit (EBITDA) forecast to a range between 970 million euros and 1 billion euros ($1.01-$1.04 billion) with an around 37.5% EBITDA margin, ...